Healthcare Sector Stocks
The Healthcare sector has a total of 1053 stocks, with a combined market cap of $9.63 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 50.14.
Market Cap
9.63T
Revenue
4.67T
Profits
192.05B
PE Ratio
50.14
Profit Margin
4.11%
Dividend Yield
0.38%
1052 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.14T | 0.22% | 1,848,889 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 646.92B | 0.91% | 5,774,781 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 506.08B | -0.12% | 3,269,357 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 368.36B | -0.08% | 3,746,593 | 450.06B |
| 5 | MRK | Merck & Co., Inc. | 349.89B | 0.86% | 9,045,746 | 66.57B |
| 6 | NVS | Novartis AG | 301.22B | 1.98% | 3,734,386 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 264.64B | -1.15% | 2,905,359 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 256.24B | 1.19% | 1,829,967 | 47.35B |
| 9 | AMGN | Amgen Inc. | 242.18B | 0.75% | 1,732,835 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 197.25B | 0.25% | 4,933,639 | 30.46B |
| 11 | ABT | Abbott Laboratories | 178.40B | -1.70% | 6,491,174 | 48.23B |
| 12 | PFE | Pfizer Inc. | 169.85B | 0.03% | 25,590,033 | 63.70B |
| 13 | NVO | Novo Nordisk A/S | 169.09B | -1.18% | 6,773,820 | 50.34B |
| 14 | DHR | Danaher Corporation | 163.22B | -0.42% | 2,498,164 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 154.56B | -1.27% | 1,697,302 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 132.06B | 0.68% | 1,019,682 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 125.73B | -0.10% | 7,778,130 | 49.19B |
| 18 | CVS | CVS Health Corporation | 116.55B | -1.51% | 4,589,292 | 412.65B |
| 19 | SYK | Stryker Corporation | 115.62B | -1.54% | 2,265,654 | 25.84B |
| 20 | MDT | Medtronic plc | 115.01B | -0.89% | 5,454,356 | 37.54B |
| 21 | MCK | McKesson Corporation | 112.75B | -2.60% | 589,754 | 410.98B |
| 22 | GSK | GSK plc | 102.24B | -0.31% | 4,770,071 | 44.05B |
| 23 | SNY | Sanofi | 100.56B | 0.24% | 2,450,745 | 55.89B |
| 24 | HCA | HCA Healthcare, Inc. | 97.42B | -3.29% | 2,907,123 | 78.70B |
| 25 | ELV | Elevance Health, Inc. | 91.07B | -2.28% | 1,536,124 | 201.83B |
| 26 | MRNA | Moderna, Inc. | 83.03B | 4.59% | 17,617,526 | 2.23B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 81.49B | 1.04% | 726,087 | 15.53B |
| 28 | CI | The Cigna Group | 78.82B | -2.45% | 1,362,008 | 282.38B |
| 29 | BSX | Boston Scientific Corporation | 65.30B | -1.14% | 15,138,810 | 21.00B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 64.80B | -0.78% | 2,147,199 | 28.42B |
| 31 | COR | Cencora, Inc. | 62.09B | -1.40% | 1,123,070 | 332.77B |
| 32 | NTRA | Natera, Inc. | 59.22B | 1.46% | 1,713,057 | 2.71B |
| 33 | CAH | Cardinal Health, Inc. | 57.07B | -2.02% | 1,631,577 | 254.25B |
| 34 | ARGX | argenx SE | 54.55B | 1.51% | 290,150 | 5.92B |
| 35 | BDX | Becton, Dickinson and Company | 53.12B | -0.69% | 1,153,158 | 22.48B |
| 36 | EW | Edwards Lifesciences Corporation | 52.35B | 0.29% | 3,020,237 | 6.51B |
| 37 | VEEV | Veeva Systems Inc. | 50.75B | -1.48% | 1,356,648 | 3.46B |
| 38 | A | Agilent Technologies, Inc. | 50.04B | 0.87% | 2,292,281 | 7.37B |
| 39 | HUM | Humana Inc. | 49.82B | -0.57% | 697,312 | 145.68B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 47.07B | 1.10% | 5,591,150 | 17.32B |
| 41 | WAT | Waters Corporation | 46.03B | 2.76% | 797,344 | 4.64B |
| 42 | IQV | IQVIA Holdings Inc. | 44.75B | -0.75% | 2,097,263 | 17.31B |
| 43 | IDXX | IDEXX Laboratories, Inc. | 44.22B | -1.57% | 488,987 | 4.55B |
| 44 | HLN | Haleon plc | 43.56B | -1.18% | 15,855,211 | 14.80B |
| 45 | MDLN | Medline Inc. | 42.57B | -3.89% | 10,653,632 | 29.94B |
| 46 | ILMN | Illumina, Inc. | 42.20B | 3.11% | 1,783,239 | 4.49B |
| 47 | ONC | BeOne Medicines AG | 41.62B | -1.30% | 518,278 | 6.13B |
| 48 | RVMD | Revolution Medicines, Inc. | 39.91B | 1.26% | 1,171,916 | - |
| 49 | RPRX | Royalty Pharma plc | 37.54B | 0.80% | 2,701,852 | 2.54B |
| 50 | BIIB | Biogen Inc. | 37.34B | 0.19% | 1,393,180 | 10.03B |
| 51 | RMD | ResMed Inc. | 35.27B | -0.95% | 936,667 | 5.65B |
| 52 | CNC | Centene Corporation | 34.02B | 1.00% | 11,672,564 | 180.41B |
| 53 | MTD | Mettler-Toledo International Inc. | 33.77B | 0.94% | 140,973 | 4.13B |
| 54 | ALC | Alcon Inc. | 33.31B | -0.81% | 1,109,391 | 10.86B |
| 55 | ZTS | Zoetis Inc. | 32.33B | -3.38% | 2,834,489 | 9.53B |
| 56 | GEHC | GE HealthCare Technologies Inc. | 32.12B | -1.21% | 5,056,612 | 21.27B |
| 57 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.35B | -0.38% | 1,603,233 | 4.80B |
| 58 | DXCM | DexCom, Inc. | 29.65B | -0.01% | 5,159,369 | 4.97B |
| 59 | WST | West Pharmaceutical Services, Inc. | 28.03B | 0.90% | 790,686 | 3.33B |
| 60 | LH | Labcorp Holdings Inc. | 26.86B | 0.38% | 799,604 | 14.35B |
| 61 | GMAB | Genmab A/S | 26.69B | -0.03% | 4,929,090 | 4.13B |
| 62 | DGX | Quest Diagnostics Incorporated | 26.69B | -0.16% | 919,012 | 11.84B |
| 63 | ROIV | Roivant Sciences Ltd. | 26.39B | 1.36% | 6,561,762 | 7.53M |
| 64 | PHG | Koninklijke Philips N.V. | 25.90B | -0.60% | 1,424,446 | 20.18B |
| 65 | UTHR | United Therapeutics Corporation | 25.36B | -0.28% | 457,405 | 3.15B |
| 66 | GH | Guardant Health, Inc. | 23.89B | 2.78% | 1,486,246 | 1.18B |
| 67 | INCY | Incyte Corporation | 23.63B | 2.90% | 2,230,883 | 5.82B |
| 68 | STE | STERIS plc | 22.28B | -0.71% | 459,470 | 6.04B |
| 69 | BNTX | BioNTech SE | 21.87B | 0.23% | 1,076,436 | 3.03B |
| 70 | VTRS | Viatris Inc. | 21.50B | 2.35% | 6,070,616 | 14.74B |
| 71 | THC | Tenet Healthcare Corporation | 21.10B | -2.57% | 1,223,452 | 21.81B |
| 72 | INSM | Insmed Incorporated | 20.74B | 1.75% | 3,349,357 | 1.14B |
| 73 | MEDP | Medpace Holdings, Inc. | 18.85B | -0.44% | 195,585 | 2.84B |
| 74 | ZBH | Zimmer Biomet Holdings, Inc. | 18.32B | -1.42% | 1,731,624 | 8.51B |
| 75 | RVTY | Revvity, Inc. | 18.06B | 0.92% | 1,551,641 | 2.91B |
| 76 | CRL | Charles River Laboratories International, Inc. | 17.13B | 0.44% | 1,159,389 | 4.00B |
| 77 | EXEL | Exelixis, Inc. | 16.19B | 0.37% | 1,431,111 | 2.44B |
| 78 | ASND | Ascendis Pharma A/S | 16.15B | 0.29% | 599,057 | 1.20B |
| 79 | NBIX | Neurocrine Biosciences, Inc. | 14.84B | 0.09% | 1,179,296 | 3.37B |
| 80 | HALO | Halozyme Therapeutics, Inc. | 14.58B | 0.38% | 1,699,311 | 1.66B |
| 81 | SOLV | Solventum Corporation | 14.13B | -3.30% | 1,320,171 | 8.31B |
| 82 | ICLR | ICON Public Limited Company | 14.12B | -0.44% | 890,645 | 8.29B |
| 83 | BBIO | BridgeBio Pharma, Inc. | 13.56B | 1.79% | 2,041,947 | 713.07M |
| 84 | JAZZ | Jazz Pharmaceuticals plc | 13.42B | 0.53% | 605,747 | 4.60B |
| 85 | TEM | Tempus AI, Inc. | 13.02B | 7.43% | 5,081,951 | 1.43B |
| 86 | BAX | Baxter International Inc. | 12.88B | -1.46% | 5,489,915 | 11.47B |
| 87 | PEN | Penumbra, Inc. | 12.76B | -0.36% | 407,848 | 1.50B |
| 88 | SNN | Smith & Nephew plc | 12.35B | -1.21% | 799,043 | 6.30B |
| 89 | SMMT | Summit Therapeutics Inc. | 12.26B | 5.72% | 5,045,487 | - |
| 90 | BTSG | BrightSpring Health Services, Inc. | 12.16B | -0.88% | 2,286,486 | 14.37B |
| 91 | EHC | Encompass Health Corporation | 11.99B | -2.07% | 578,570 | 6.21B |
| 92 | FMS | Fresenius Medical Care AG | 11.85B | -1.10% | 784,304 | 22.19B |
| 93 | DVA | DaVita Inc. | 11.59B | -1.27% | 566,759 | 14.01B |
| 94 | AVTR | Avantor, Inc. | 11.59B | -0.93% | 10,689,544 | 6.56B |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 11.45B | - | 4,202,792 | 3.44B |
| 96 | COO | The Cooper Companies, Inc. | 11.39B | -2.06% | 2,166,717 | 4.24B |
| 97 | TECH | Bio-Techne Corporation | 11.39B | -0.12% | 2,429,343 | 1.22B |
| 98 | ELAN | Elanco Animal Health Incorporated | 11.32B | -1.35% | 4,985,659 | 5.02B |
| 99 | GMED | Globus Medical, Inc. | 10.86B | -1.14% | 507,438 | 3.14B |
| 100 | ALGN | Align Technology, Inc. | 10.79B | -0.20% | 681,778 | 4.14B |
| 101 | BMRN | BioMarin Pharmaceutical Inc. | 10.71B | -0.72% | 2,458,816 | 3.41B |
| 102 | GKOS | Glaukos Corporation | 10.68B | 1.63% | 1,327,501 | 612.84M |
| 103 | UHS | Universal Health Services, Inc. | 10.45B | -4.52% | 1,246,513 | 18.35B |
| 104 | PODD | Insulet Corporation | 10.39B | 0.38% | 943,797 | 3.05B |
| 105 | MOH | Molina Healthcare, Inc. | 10.39B | -2.60% | 606,146 | 42.08B |
| 106 | QGEN | Qiagen N.V. | 10.38B | -0.40% | 4,368,704 | 2.10B |
| 107 | BIO | Bio-Rad Laboratories, Inc. | 10.19B | 2.30% | 167,156 | 2.59B |
| 108 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.17B | 0.59% | 209,573 | 1.28B |
| 109 | TXG | 10x Genomics, Inc. | 10.17B | 6.94% | 2,128,712 | 616.91M |
| 110 | TWST | Twist Bioscience Corporation | 10.02B | 10.05% | 1,758,019 | 431.80M |
| 111 | RGEN | Repligen Corporation | 9.92B | -2.43% | 2,114,805 | 805.61M |
| 112 | ENSG | The Ensign Group, Inc. | 9.80B | -4.19% | 673,914 | 5.67B |
| 113 | KYMR | Kymera Therapeutics, Inc. | 9.78B | 2.38% | 828,856 | 105.00M |
| 114 | OSCR | Oscar Health, Inc. | 9.67B | 0.80% | 2,837,096 | 15.32B |
| 115 | PCVX | Vaxcyte, Inc. | 9.55B | 1.17% | 2,606,678 | - |
| 116 | CAI | Caris Life Sciences, Inc. | 9.51B | 3.74% | 3,380,439 | 989.61M |
| 117 | KRYS | Krystal Biotech, Inc. | 9.49B | 2.21% | 212,806 | 440.48M |
| 118 | CORT | Corcept Therapeutics Incorporated | 9.47B | 0.53% | 925,414 | 830.81M |
| 119 | HSIC | Henry Schein, Inc. | 9.39B | -0.31% | 709,804 | 13.60B |
| 120 | SYRE | Spyre Therapeutics, Inc. | 9.26B | 6.60% | 944,279 | - |
| 121 | BRKR | Bruker Corporation | 9.25B | 4.31% | 2,384,766 | 3.50B |
| 122 | HNGE | Hinge Health, Inc. | 9.19B | 1.96% | 1,083,060 | 720.06M |
| 123 | IBRX | ImmunityBio, Inc. | 9.15B | 10.50% | 10,506,141 | 165.79M |
| 124 | PTGX | Protagonist Therapeutics, Inc. | 9.13B | 0.57% | 865,918 | 281.99M |
| 125 | CYTK | Cytokinetics, Incorporated | 8.55B | 1.30% | 1,147,811 | 67.67M |
| 126 | HQY | HealthEquity, Inc. | 8.34B | -2.77% | 673,526 | 1.36B |
| 127 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.34B | 0.08% | 2,118,834 | 669.50M |
| 128 | ATR | AptarGroup, Inc. | 8.04B | -0.44% | 445,276 | 3.93B |
| 129 | TGTX | TG Therapeutics, Inc. | 8.01B | 3.01% | 1,484,829 | 799.54M |
| 130 | ABVX | ABIVAX Société Anonyme | 7.76B | 0.58% | 740,185 | 5.33M |
| 131 | PACS | PACS Group, Inc. | 7.58B | -1.87% | 748,892 | 5.55B |
| 132 | PRAX | Praxis Precision Medicines, Inc. | 7.47B | 0.07% | 388,210 | 7.46M |
| 133 | AMRX | Amneal Pharmaceuticals, Inc. | 7.47B | 2.00% | 2,887,806 | 3.12B |
| 134 | AXSM | Axsome Therapeutics, Inc. | 7.45B | -1.29% | 1,104,042 | 776.57M |
| 135 | ALKS | Alkermes plc | 7.44B | -0.27% | 1,322,006 | 1.67B |
| 136 | IONS | Ionis Pharmaceuticals, Inc. | 7.31B | 1.24% | 2,376,771 | 874.09M |
| 137 | GRFS | Grifols, S.A. | 7.08B | 2.27% | 840,515 | 8.48B |
| 138 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.96B | 22.23% | 2,319,644 | 945.96M |
| 139 | GRAL | GRAIL, Inc. | 6.73B | 7.65% | 1,769,455 | 165.26M |
| 140 | CHE | Chemed Corporation | 6.63B | -0.74% | 191,318 | 2.66B |
| 141 | IOVA | Iovance Biotherapeutics, Inc. | 6.60B | 5.81% | 8,803,995 | 324.97M |
| 142 | LNTH | Lantheus Holdings, Inc. | 6.54B | 0.23% | 761,404 | 1.56B |
| 143 | HIMS | Hims & Hers Health, Inc. | 6.51B | 1.20% | 6,915,370 | 2.58B |
| 144 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.35B | 3.03% | 398,019 | 239.92M |
| 145 | ORKA | Oruka Therapeutics, Inc. | 6.34B | 6.07% | 1,205,195 | - |
| 146 | BLCO | Bausch + Lomb Corporation | 6.29B | 0.23% | 450,795 | 5.32B |
| 147 | LGND | Ligand Pharmaceuticals Incorporated | 6.21B | 1.11% | 143,325 | 290.54M |
| 148 | IMVT | Immunovant, Inc. | 5.97B | 2.52% | 1,057,999 | - |
| 149 | DOCS | Doximity, Inc. | 5.92B | 0.48% | 2,005,785 | 655.57M |
| 150 | TFX | Teleflex Incorporated | 5.89B | 1.61% | 878,867 | 2.25B |
| 151 | MANE | Veradermics, Incorporated | 5.88B | 2.42% | 466,844 | - |
| 152 | BLTE | Belite Bio, Inc | 5.87B | 1.65% | 138,078 | - |
| 153 | RDNT | RadNet, Inc. | 5.79B | 4.98% | 1,272,495 | 2.27B |
| 154 | KOD | Kodiak Sciences Inc. | 5.73B | 1.92% | 1,010,286 | - |
| 155 | MMSI | Merit Medical Systems, Inc. | 5.58B | -0.71% | 731,977 | 1.58B |
| 156 | CGON | CG Oncology, Inc. | 5.58B | 2.24% | 709,340 | 6.23M |
| 157 | COGT | Cogent Biosciences, Inc. | 5.56B | 3.56% | 1,400,170 | - |
| 158 | MIRM | Mirum Pharmaceuticals, Inc. | 5.56B | 2.75% | 563,256 | 618.07M |
| 159 | HAE | Haemonetics Corporation | 5.46B | 0.65% | 741,312 | 1.35B |
| 160 | BLLN | BillionToOne, Inc. | 5.38B | 2.34% | 372,266 | 397.41M |
| 161 | WAY | Waystar Holding Corp. | 5.37B | -2.34% | 1,295,534 | 1.21B |
| 162 | STVN | Stevanato Group S.p.A. | 5.36B | -1.21% | 250,523 | 1.40B |
| 163 | MMED | MiniMed Group, Inc. | 5.33B | 1.45% | 8,001,398 | 3.22B |
| 164 | ERAS | Erasca, Inc. | 5.32B | 1.53% | 5,825,712 | - |
| 165 | SHC | Sotera Health Company | 5.28B | 0.54% | 1,821,640 | 1.22B |
| 166 | PTCT | PTC Therapeutics, Inc. | 5.18B | 1.67% | 1,117,061 | 1.01B |
| 167 | SRRK | Scholar Rock Holding Corporation | 5.17B | 1.87% | 1,157,862 | - |
| 168 | CON | Concentra Group Holdings Parent, Inc. | 5.10B | -0.50% | 1,035,578 | 2.29B |
| 169 | HTFL | HeartFlow, Inc. | 5.03B | 1.43% | 1,793,852 | 212.07M |
| 170 | LFST | LifeStance Health Group, Inc. | 5.01B | 0.31% | 3,164,960 | 1.58B |
| 171 | DFTX | Definium Therapeutics, Inc. | 4.98B | 3.92% | 1,282,329 | - |
| 172 | CRSP | CRISPR Therapeutics AG | 4.98B | 5.02% | 1,166,523 | 13.39M |
| 173 | TVTX | Travere Therapeutics, Inc. | 4.80B | 1.82% | 3,450,122 | 591.33M |
| 174 | OPCH | Option Care Health, Inc. | 4.69B | 0.19% | 2,512,945 | 5.69B |
| 175 | DNTH | Dianthus Therapeutics, Inc. | 4.45B | 0.24% | 748,633 | 1.90M |
| 176 | LIVN | LivaNova PLC | 4.43B | -0.30% | 383,594 | 1.47B |
| 177 | ADPT | Adaptive Biotechnologies Corporation | 4.41B | 5.29% | 1,535,482 | 308.08M |
| 178 | ITGR | Integer Holdings Corporation | 4.31B | 0.17% | 533,925 | 1.84B |
| 179 | EWTX | Edgewise Therapeutics, Inc. | 4.29B | 0.92% | 942,036 | - |
| 180 | LEGN | Legend Biotech Corporation | 4.18B | 5.74% | 2,121,782 | 1.27B |
| 181 | ABCL | AbCellera Biologics Inc. | 4.16B | 6.21% | 3,458,324 | 66.17M |
| 182 | RLAY | Relay Therapeutics, Inc. | 4.13B | 3.97% | 2,258,221 | 10.35M |
| 183 | INDV | Indivior Pharmaceuticals, Inc. | 4.10B | 0.46% | 2,410,632 | 1.33B |
| 184 | ICUI | ICU Medical, Inc. | 4.08B | -1.66% | 323,145 | 2.16B |
| 185 | IRTC | iRhythm Holdings, Inc. | 4.08B | 1.49% | 380,381 | 825.34M |
| 186 | LQDA | Liquidia Corporation | 4.07B | 3.89% | 2,700,291 | 450.91M |
| 187 | VCYT | Veracyte, Inc. | 4.04B | 4.32% | 1,809,888 | 561.90M |
| 188 | ARQT | Arcutis Biotherapeutics, Inc. | 3.98B | -0.41% | 2,224,122 | 463.98M |
| 189 | TNGX | Tango Therapeutics, Inc. | 3.86B | 3.13% | 3,322,765 | 53.81M |
| 190 | PLSE | Pulse Biosciences, Inc. | 3.79B | 1.03% | 328,950 | 1.19M |
| 191 | NVST | Envista Holdings Corporation | 3.79B | -0.34% | 2,059,163 | 2.86B |
| 192 | RGC | Regencell Bioscience Holdings Limited | 3.70B | 10.36% | 255,673 | - |
| 193 | CDNA | CareDx, Inc. | 3.65B | 2.07% | 1,175,858 | 458.09M |
| 194 | OGN | Organon & Co. | 3.61B | 0.07% | 1,865,054 | 6.13B |
| 195 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.55B | 4.47% | 1,122,453 | -665.00K |
| 196 | IRON | Disc Medicine, Inc. | 3.55B | 2.88% | 1,469,693 | - |
| 197 | XENE | Xenon Pharmaceuticals Inc. | 3.49B | 0.67% | 1,089,963 | 7.50M |
| 198 | ACAD | Acadia Pharmaceuticals Inc. | 3.48B | 2.18% | 1,332,124 | 1.14B |
| 199 | CELC | Celcuity Inc. | 3.33B | 3.45% | 837,304 | - |
| 200 | NHC | National HealthCare Corporation | 3.32B | -5.32% | 150,445 | 1.56B |
| 201 | PBLS | Parabilis Medicines, Inc. | 3.27B | 5.91% | 1,572,596 | 148.00K |
| 202 | IDYA | IDEAYA Biosciences, Inc. | 3.23B | 1.89% | 1,000,822 | 234.13M |
| 203 | ELVN | Enliven Therapeutics, Inc. | 3.20B | 5.30% | 3,308,393 | - |
| 204 | DYN | Dyne Therapeutics, Inc. | 3.16B | 7.76% | 3,000,314 | - |
| 205 | ATRC | AtriCure, Inc. | 3.13B | 0.70% | 783,123 | 569.62M |
| 206 | TARS | Tarsus Pharmaceuticals, Inc. | 3.11B | 1.04% | 747,960 | 606.33M |
| 207 | WRBY | Warby Parker Inc. | 3.10B | -0.83% | 1,239,251 | 911.61M |
| 208 | DNLI | Denali Therapeutics Inc. | 3.07B | 3.00% | 1,481,933 | 3.60M |
| 209 | TLX | Telix Pharmaceuticals Limited | 3.06B | 0.44% | 224,798 | 890.79M |
| 210 | SGRY | Surgery Partners, Inc. | 3.03B | 0.47% | 11,201,000 | 3.37B |
| 211 | NRIX | Nurix Therapeutics, Inc. | 2.92B | 4.50% | 2,563,015 | 701.94M |
| 212 | VKTX | Viking Therapeutics, Inc. | 2.90B | 2.81% | 3,327,407 | - |
| 213 | PRVA | Privia Health Group, Inc. | 2.79B | -1.49% | 965,331 | 2.36B |
| 214 | ACHC | Acadia Healthcare Company, Inc. | 2.78B | -4.59% | 2,337,739 | 3.37B |
| 215 | AVAH | Aveanna Healthcare Holdings Inc. | 2.77B | -3.64% | 1,537,513 | 2.60B |
| 216 | VRDN | Viridian Therapeutics, Inc. | 2.73B | 3.21% | 2,808,628 | 71.13M |
| 217 | NEOG | Neogen Corporation | 2.72B | 2.13% | 3,305,123 | 884.00M |
| 218 | ZLAB | Zai Lab Limited | 2.65B | -3.12% | 1,539,674 | 449.61M |
| 219 | RCUS | Arcus Biosciences, Inc. | 2.57B | 2.14% | 2,231,835 | 117.00M |
| 220 | MBX | MBX Biosciences, Inc. | 2.55B | 5.33% | 492,989 | - |
| 221 | GRDN | Guardian Pharmacy Services, Inc. | 2.51B | 0.94% | 357,130 | 1.46B |
| 222 | ADMA | ADMA Biologics, Inc. | 2.50B | 0.95% | 2,219,170 | 512.28M |
| 223 | BEAM | Beam Therapeutics Inc. | 2.49B | 4.67% | 2,750,551 | 156.04M |
| 224 | CLOV | Clover Health Investments, Corp. | 2.46B | 1.54% | 3,046,773 | 2.48B |
| 225 | SLS | SELLAS Life Sciences Group, Inc. | 2.46B | 7.32% | 5,697,413 | - |
| 226 | NAMS | NewAmsterdam Pharma Company N.V. | 2.45B | 4.97% | 1,967,732 | 7.12M |
| 227 | RXRX | Recursion Pharmaceuticals, Inc. | 2.42B | 6.58% | 20,554,590 | 54.86M |
| 228 | TMDX | TransMedics Group, Inc. | 2.42B | -1.27% | 825,727 | 668.47M |
| 229 | SUPN | Supernus Pharmaceuticals, Inc. | 2.38B | 0.47% | 1,075,467 | 830.44M |
| 230 | CLDX | Celldex Therapeutics, Inc. | 2.37B | 2.20% | 746,577 | 158.00K |
| 231 | BHC | Bausch Health Companies Inc. | 2.36B | -0.63% | 1,562,810 | 10.85B |
| 232 | HCM | HUTCHMED (China) Limited | 2.33B | -3.29% | 51,506 | 549.12M |
| 233 | FTRE | Fortrea Holdings Inc. | 2.32B | 2.52% | 1,973,374 | 2.68B |
| 234 | BHVN | Biohaven Ltd. | 2.31B | 5.81% | 2,430,566 | - |
| 235 | AUPH | Aurinia Pharmaceuticals Inc. | 2.30B | 1.23% | 494,477 | 311.51M |
| 236 | MD | Pediatrix Medical Group, Inc. | 2.29B | -0.69% | 668,610 | 1.95B |
| 237 | UFPT | UFP Technologies, Inc. | 2.28B | 1.22% | 73,167 | 631.64M |
| 238 | BKD | Brookdale Senior Living Inc. | 2.28B | -2.36% | 8,753,564 | 2.93B |
| 239 | AGIO | Agios Pharmaceuticals, Inc. | 2.27B | 3.20% | 738,982 | 98.34M |
| 240 | PBH | Prestige Consumer Healthcare Inc. | 2.25B | -1.58% | 576,289 | 1.10B |
| 241 | PHVS | Pharvaris N.V. | 2.24B | 1.30% | 230,110 | - |
| 242 | XNCR | Xencor, Inc. | 2.23B | 2.78% | 2,108,990 | 104.97M |
| 243 | PRGO | Perrigo Company plc | 2.22B | 1.26% | 2,233,156 | 4.14B |
| 244 | NEO | NeoGenomics, Inc. | 2.22B | 3.48% | 2,753,351 | 766.30M |
| 245 | ADUS | Addus HomeCare Corporation | 2.22B | 0.06% | 216,637 | 1.48B |
| 246 | ALMR | Alamar Biosciences, Inc. | 2.22B | 5.07% | 508,077 | 100.42M |
| 247 | VCEL | Vericel Corporation | 2.22B | 0.53% | 558,356 | 306.30M |
| 248 | HRMY | Harmony Biosciences Holdings, Inc. | 2.21B | 3.04% | 736,893 | 959.90M |
| 249 | PGEN | Precigen, Inc. | 2.20B | 1.82% | 3,790,134 | 85.72M |
| 250 | AXGN | Axogen, Inc. | 2.20B | -1.47% | 2,460,969 | 251.17M |
| 251 | VERA | Vera Therapeutics, Inc. | 2.16B | 5.97% | 1,069,716 | - |
| 252 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.14B | 8.97% | 3,110,349 | 208.78M |
| 253 | IMNM | Immunome, Inc. | 2.13B | 4.92% | 1,226,154 | 4.02M |
| 254 | PGNY | Progyny, Inc. | 2.13B | -1.46% | 923,742 | 1.31B |
| 255 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.07B | 2.79% | 8,753,269 | 940.61M |
| 256 | INSP | Inspire Medical Systems, Inc. | 2.06B | 0.41% | 667,721 | 898.74M |
| 257 | SEPN | Septerna, Inc. | 2.06B | 6.67% | 261,807 | 98.88M |
| 258 | TRLV | Trulieve Cannabis Corp. | 2.05B | -1.39% | 867,923 | 1.14B |
| 259 | ZYME | Zymeworks Inc. | 2.05B | 1.69% | 1,125,676 | 37.13M |
| 260 | ADRX | ADARx Pharmaceuticals, Inc. | 2.03B | 1.80% | 293,616 | 6.13M |
| 261 | LKFT | Lakefront Biotherapeutics NV | 2.01B | 0.43% | 170,821 | 1.13B |
| 262 | SDGR | Schrödinger, Inc. | 2.00B | 9.06% | 1,318,952 | 259.04M |
| 263 | SRPT | Sarepta Therapeutics, Inc. | 2.00B | 5.06% | 2,225,764 | 1.97B |
| 264 | ESTA | Establishment Labs Holdings Inc. | 2.00B | 1.78% | 489,949 | 245.82M |
| 265 | BFLY | Butterfly Network, Inc. | 1.97B | 10.81% | 4,917,790 | 112.14M |
| 266 | VIR | Vir Biotechnology, Inc. | 1.96B | 4.80% | 1,973,437 | 303.23M |
| 267 | LMAT | LeMaitre Vascular, Inc. | 1.92B | -0.62% | 221,960 | 262.43M |
| 268 | PVLA | Palvella Therapeutics, Inc. | 1.92B | 5.29% | 178,580 | - |
| 269 | TRAX | First Tracks Biotherapeutics, Inc. | 1.91B | 4.37% | 617,999 | - |
| 270 | XERS | Xeris Biopharma Holdings, Inc. | 1.91B | 2.35% | 1,521,978 | 335.41M |
| 271 | TRVI | Trevi Therapeutics, Inc. | 1.90B | 6.71% | 2,099,864 | - |
| 272 | ASTH | Astrana Health, Inc. | 1.89B | -0.78% | 310,903 | 3.84B |
| 273 | NBTX | Nanobiotix S.A. | 1.88B | 9.51% | 129,979 | 13.15M |
| 274 | WGS | GeneDx Holdings Corp. | 1.87B | 2.42% | 926,802 | 454.43M |
| 275 | MLYS | Mineralys Therapeutics, Inc. | 1.87B | 2.77% | 3,199,893 | - |
| 276 | XRAY | DENTSPLY SIRONA Inc. | 1.86B | 1.41% | 3,936,826 | 3.64B |
| 277 | ABSI | Absci Corporation | 1.81B | 11.85% | 5,836,655 | 1.56M |
| 278 | AMN | AMN Healthcare Services, Inc. | 1.81B | -4.47% | 1,475,125 | 3.43B |
| 279 | COAG | Hemab Therapeutics Holdings, Inc. | 1.79B | 6.61% | 380,009 | - |
| 280 | KMTS | Kestra Medical Technologies, Ltd. | 1.79B | 1.94% | 514,266 | 106.73M |
| 281 | BRVE | Braveheart Bio, Inc. | 1.78B | -0.23% | 156,109 | - |
| 282 | ZBIO | Zenas BioPharma, Inc. | 1.78B | 0.22% | 581,011 | 1.00M |
| 283 | MAZE | Maze Therapeutics, Inc. | 1.76B | 2.00% | 624,979 | 20.00M |
| 284 | NTLA | Intellia Therapeutics, Inc. | 1.72B | 9.06% | 3,850,224 | 59.51M |
| 285 | AZTA | Azenta, Inc. | 1.71B | 5.14% | 1,676,549 | 613.81M |
| 286 | PSNL | Personalis, Inc. | 1.71B | 0.63% | 1,829,241 | 69.67M |
| 287 | NVCR | NovoCure Limited | 1.70B | 1.53% | 2,465,497 | 699.19M |
| 288 | KLRA | Kailera Therapeutics, Inc. | 1.70B | 2.82% | 841,655 | - |
| 289 | GENB | Generate Biomedicines, Inc. | 1.70B | 6.96% | 755,121 | 26.48M |
| 290 | ALVO | Alvotech | 1.70B | 2.81% | 733,306 | 494.61M |
| 291 | MESO | Mesoblast Limited | 1.69B | 6.38% | 206,767 | 120.25M |
| 292 | STOK | Stoke Therapeutics, Inc. | 1.69B | 2.63% | 1,325,213 | 27.59M |
| 293 | QURE | uniQure N.V. | 1.68B | 12.15% | 1,572,208 | 18.67M |
| 294 | ATEC | Alphatec Holdings, Inc. | 1.68B | -0.28% | 4,116,512 | 815.05M |
| 295 | OMCL | Omnicell, Inc. | 1.68B | -0.57% | 580,980 | 1.25B |
| 296 | CERT | Certara, Inc. | 1.67B | 3.20% | 2,416,682 | 421.75M |
| 297 | ALHC | Alignment Healthcare, Inc. | 1.67B | 2.03% | 5,138,227 | 4.58B |
| 298 | ARDT | Ardent Health, Inc. | 1.67B | -2.87% | 372,715 | 6.41B |
| 299 | URGN | UroGen Pharma Ltd. | 1.66B | -0.38% | 1,033,086 | 188.73M |
| 300 | NVAX | Novavax, Inc. | 1.65B | 6.60% | 6,774,369 | 413.80M |
| 301 | RARE | Ultragenyx Pharmaceutical Inc. | 1.65B | 4.17% | 4,944,432 | 717.00M |
| 302 | IMCR | Immunocore Holdings plc | 1.65B | 2.17% | 314,105 | 430.78M |
| 303 | HCSG | Healthcare Services Group, Inc. | 1.64B | -2.99% | 882,379 | 1.88B |
| 304 | CMPS | COMPASS Pathways plc | 1.64B | 6.88% | 2,275,077 | - |
| 305 | NUVB | Nuvation Bio Inc. | 1.60B | 0.89% | 5,055,357 | 169.90M |
| 306 | PAHC | Phibro Animal Health Corporation | 1.56B | -1.67% | 118,865 | 1.52B |
| 307 | SNDA | Sonida Senior Living, Inc. | 1.55B | -2.21% | 464,464 | 481.07M |
| 308 | GPCR | Structure Therapeutics Inc. | 1.54B | 2.13% | 731,598 | - |
| 309 | ANIP | ANI Pharmaceuticals, Inc. | 1.53B | -1.97% | 285,231 | 978.38M |
| 310 | AGL | agilon health, inc. | 1.52B | 0.34% | 123,836 | 5.92B |
| 311 | INVA | Innoviva, Inc. | 1.51B | -0.52% | 584,406 | 440.00M |
| 312 | LYCA | Lycia Therapeutics, Inc. | 1.51B | -9.50% | 426,732 | 4.44M |
| 313 | ANAB | AnaptysBio, Inc. | 1.48B | 1.76% | 349,577 | 106.09M |
| 314 | TYRA | Tyra Biosciences, Inc. | 1.48B | 5.39% | 522,927 | - |
| 315 | OCUL | Ocular Therapeutix, Inc. | 1.48B | 3.86% | 2,215,190 | 52.06M |
| 316 | ETON | Eton Pharmaceuticals, Inc. | 1.46B | 1.97% | 340,279 | 105.60M |
| 317 | PNTG | The Pennant Group, Inc. | 1.46B | -2.11% | 422,666 | 1.10B |
| 318 | PCRX | Pacira BioSciences, Inc. | 1.45B | 0.05% | 471,786 | 746.16M |
| 319 | NUTX | Nutex Health Inc. | 1.43B | -0.36% | 128,113 | 846.72M |
| 320 | CNMD | CONMED Corporation | 1.41B | -1.01% | 505,947 | 1.37B |
| 321 | INBX | Inhibrx Biosciences, Inc. | 1.41B | 7.96% | 374,208 | 1.30M |
| 322 | FRNM | Freenome, Inc. | 1.40B | 2.52% | 516,671 | 35.41M |
| 323 | TSHA | Taysha Gene Therapies, Inc. | 1.38B | 5.99% | 2,798,314 | 5.49M |
| 324 | GHRS | GH Research PLC | 1.37B | 4.38% | 299,970 | - |
| 325 | KRSA | Korsana Biosciences, Inc. | 1.37B | -6.29% | 196,731 | - |
| 326 | DMRA | Damora Therapeutics, Inc. | 1.36B | 3.29% | 286,092 | - |
| 327 | TNDM | Tandem Diabetes Care, Inc. | 1.34B | 1.69% | 2,059,578 | 1.04B |
| 328 | RAPP | Rapport Therapeutics, Inc. | 1.32B | 8.72% | 441,127 | 20.00M |
| 329 | USPH | U.S. Physical Therapy, Inc. | 1.30B | -1.48% | 187,947 | 804.27M |
| 330 | NKTR | Nektar Therapeutics | 1.30B | 1.39% | 568,310 | 54.59M |
| 331 | LBRX | LB Pharmaceuticals Inc | 1.28B | 0.76% | 236,345 | - |
| 332 | KARD | Kardigan, Inc. | 1.27B | 7.68% | 452,701 | - |
| 333 | OMER | Omeros Corporation | 1.27B | 7.37% | 894,850 | 38.42M |
| 334 | AAPG | Ascentage Pharma Group International | 1.26B | -3.88% | 9,965 | 94.61M |
| 335 | CRON | Cronos Group Inc. | 1.25B | 2.11% | 751,446 | 179.09M |
| 336 | DRTS | Alpha Tau Medical Ltd. | 1.25B | 4.81% | 342,039 | - |
| 337 | INNV | InnovAge Holding Corp. | 1.24B | -1.62% | 388,255 | 989.71M |
| 338 | ENOV | Enovis Corporation | 1.24B | 1.80% | 1,618,765 | 2.30B |
| 339 | SVRA | Savara Inc. | 1.24B | 7.52% | 3,591,156 | - |
| 340 | REPL | Replimune Group, Inc. | 1.23B | 4.65% | 4,298,177 | - |
| 341 | VSTM | Verastem, Inc. | 1.23B | 1.00% | 4,704,924 | 87.53M |
| 342 | SNDX | Syndax Pharmaceuticals, Inc. | 1.22B | 3.56% | 2,704,437 | 252.25M |
| 343 | BVS | Bioventus Inc. | 1.21B | -2.04% | 409,829 | 581.85M |
| 344 | STAA | STAAR Surgical Company | 1.21B | 4.00% | 604,963 | 339.59M |
| 345 | AHG | Akso Health Group | 1.21B | 11.02% | 11,323 | 13.83M |
| 346 | OPK | OPKO Health, Inc. | 1.20B | -1.23% | 4,158,230 | 587.90M |
| 347 | SLN | Silence Therapeutics plc | 1.19B | - | 1,488,165 | 615.00K |
| 348 | GDRX | GoodRx Holdings, Inc. | 1.19B | -2.25% | 796,204 | 785.23M |
| 349 | TDOC | Teladoc Health, Inc. | 1.17B | 3.37% | 3,976,832 | 2.49B |
| 350 | OMDA | Omada Health, Inc. | 1.16B | -1.20% | 662,655 | 309.76M |
| 351 | BCAX | Bicara Therapeutics Inc. | 1.16B | 3.49% | 609,330 | - |
| 352 | VOR | Vor Biopharma Inc. | 1.16B | 6.60% | 640,459 | - |
| 353 | AVLN | Avalyn Pharma Inc. | 1.15B | -4.83% | 961,285 | - |
| 354 | SPTX | Seaport Therapeutics, Inc. | 1.14B | 2.16% | 219,052 | - |
| 355 | PRCT | PROCEPT BioRobotics Corporation | 1.13B | -0.15% | 709,301 | 337.34M |
| 356 | BBNX | Beta Bionics, Inc. | 1.13B | 4.29% | 1,228,275 | 127.27M |
| 357 | LMRI | Lumexa Imaging Holdings, Inc. | 1.12B | -0.60% | 342,621 | 1.04B |
| 358 | AORT | Artivion, Inc. | 1.12B | -0.17% | 405,207 | 471.47M |
| 359 | HROW | Harrow, Inc. | 1.09B | 0.41% | 635,293 | 275.59M |
| 360 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.09B | 0.39% | 323,925 | 730.02M |
| 361 | IRMD | IRADIMED CORPORATION | 1.07B | -0.80% | 127,136 | 86.34M |
| 362 | MNKD | MannKind Corporation | 1.06B | 1.86% | 2,508,701 | 393.63M |
| 363 | JANX | Janux Therapeutics, Inc. | 1.06B | 3.42% | 687,228 | 24.00M |
| 364 | CSTL | Castle Biosciences, Inc. | 1.05B | 3.63% | 295,138 | 357.28M |
| 365 | HSTM | HealthStream, Inc. | 1.05B | -1.95% | 138,119 | 321.12M |
| 366 | CBLL | CeriBell, Inc. | 1.04B | 0.70% | 1,158,847 | 101.96M |
| 367 | CTY | City Therapeutics, Inc. | 1.04B | 0.34% | 214,807 | 14.34M |
| 368 | SGP | SpyGlass Pharma, Inc. | 1.03B | 3.31% | 69,335 | - |
| 369 | MLTX | MoonLake Immunotherapeutics | 1.02B | 1.02% | 934,414 | - |
| 370 | LTGO | Latigo Biotherapeutics, Inc. | 1.01B | -0.33% | 164,098 | - |
| 371 | IMTX | Immatics N.V. | 992.37M | 1.54% | 1,194,124 | 47.65M |
| 372 | SIBN | SI-BONE, Inc. | 960.91M | 0.61% | 482,177 | 213.60M |
| 373 | CGEM | Cullinan Therapeutics, Inc. | 955.02M | 2.06% | 488,032 | - |
| 374 | RIGL | Rigel Pharmaceuticals, Inc. | 944.27M | 1.28% | 133,063 | 276.79M |
| 375 | JBIO | Jade Biosciences, Inc. | 937.43M | 1.66% | 652,900 | - |
| 376 | ODTX | Odyssey Therapeutics, Inc. | 934.41M | 1.04% | 241,163 | 99.00K |
| 377 | ORIC | ORIC Pharmaceuticals, Inc. | 932.87M | 0.50% | 4,938,899 | - |
| 378 | IART | Integra LifeSciences Holdings Corporation | 932.83M | -0.91% | 1,431,835 | 1.66B |
| 379 | QDEL | QuidelOrtho Corporation | 931.94M | -1.31% | 2,075,870 | 2.67B |
| 380 | AKTS | Aktis Oncology, Inc. | 914.94M | 4.58% | 325,396 | 10.06M |
| 381 | ANRO | Alto Neuroscience, Inc. | 910.02M | 4.88% | 376,728 | - |
| 382 | GLUE | Monte Rosa Therapeutics, Inc. | 909.44M | 1.72% | 1,457,729 | 28.73M |
| 383 | MGTX | MeiraGTx Holdings plc | 902.80M | 2.40% | 722,537 | 397.50M |
| 384 | CRVS | Corvus Pharmaceuticals, Inc. | 886.63M | 0.86% | 1,133,566 | - |
| 385 | KURA | Kura Oncology, Inc. | 880.71M | 2.91% | 1,710,005 | 77.23M |
| 386 | OBX | Obsidian Therapeutics, Inc. | 880.26M | 2.81% | 397,720 | - |
| 387 | IVA | Inventiva S.A. | 868.08M | 0.68% | 1,782,494 | 2.81M |
| 388 | ALMS | Alumis Inc. | 859.45M | 2.00% | 2,814,879 | 7.40M |
| 389 | PHAR | Pharming Group N.V. | 851.70M | -0.25% | 19,184 | 386.75M |
| 390 | ABUS | Arbutus Biopharma Corporation | 848.77M | 2.14% | 1,622,666 | 181.72M |
| 391 | GMRS | GMR Solutions Inc. | 828.51M | -1.39% | 316,932 | 5.88B |
| 392 | APMD | Apnimed, Inc. | 811.38M | 2.85% | 365,456 | 115.12M |
| 393 | INMD | InMode Ltd. | 780.59M | -1.02% | 451,185 | 374.63M |
| 394 | AHCO | AdaptHealth Corp. | 780.44M | -1.35% | 2,665,174 | 3.36B |
| 395 | VREX | Varex Imaging Corporation | 778.05M | 0.27% | 699,122 | 865.00M |
| 396 | CTKB | Cytek Biosciences, Inc. | 777.30M | 1.53% | 1,208,145 | 206.71M |
| 397 | PRME | Prime Medicine, Inc. | 773.88M | 20.50% | 8,824,669 | 4.07M |
| 398 | HELP | Helus Pharma Inc. | 768.59M | 1.54% | 1,527,197 | - |
| 399 | PHR | Phreesia, Inc. | 762.85M | -2.54% | 465,601 | 507.79M |
| 400 | PACB | Pacific Biosciences of California, Inc. | 761.54M | 8.89% | 18,684,122 | 159.27M |
| 401 | AVBP | ArriVent BioPharma, Inc. | 759.34M | 0.26% | 1,581,966 | - |
| 402 | DNA | Ginkgo Bioworks Holdings, Inc. | 758.92M | 12.48% | 3,008,189 | 132.42M |
| 403 | COLL | Collegium Pharmaceutical, Inc. | 748.78M | -0.90% | 486,604 | 808.21M |
| 404 | ARDX | Ardelyx, Inc. | 747.56M | - | 4,862,071 | 450.89M |
| 405 | SANA | Sana Biotechnology, Inc. | 739.42M | 4.66% | 2,620,782 | - |
| 406 | SGMT | Sagimet Biosciences Inc. | 738.87M | 9.00% | 1,108,635 | - |
| 407 | GERN | Geron Corporation | 738.84M | - | 5,360,313 | 204.56M |
| 408 | OABI | OmniAb, Inc. | 721.14M | 7.59% | 1,113,208 | 38.46M |
| 409 | ACHV | Achieve Life Sciences, Inc. | 713.11M | 5.96% | 1,486,026 | - |
| 410 | ANNX | Annexon, Inc. | 712.82M | 1.62% | 2,964,361 | - |
| 411 | SLBT | SL Science Holding Limited | 701.43M | - | 38,225 | 3.27M |
| 412 | GYRE | Gyre Therapeutics, Inc. | 692.40M | 7.58% | 126,373 | 109.82M |
| 413 | ANL | Adlai Nortye Group Ltd. | 689.70M | 1.23% | 71,157 | 18.06M |
| 414 | ATTO | Attovia Therapeutics, Inc. | 684.77M | 8.07% | 454,269 | 1.80M |
| 415 | WVE | Wave Life Sciences, Inc. | 679.82M | 7.48% | 3,619,934 | 70.92M |
| 416 | STLN | Starling Oncology, Inc. | 671.63M | 4.77% | 1,314,775 | 587.24M |
| 417 | IMMX | Immix Biopharma, Inc. | 667.37M | -0.12% | 1,147,026 | - |
| 418 | DSGN | Design Therapeutics, Inc. | 665.24M | 2.80% | 388,875 | - |
| 419 | SLDB | Solid Biosciences Inc. | 663.72M | 6.54% | 1,551,480 | - |
| 420 | IAM | Iambic Therapeutics, Inc. | 663.61M | -2.85% | 439,707 | 18.25M |
| 421 | FDMT | 4D Molecular Therapeutics, Inc. | 660.72M | 8.43% | 1,134,654 | 92.01M |
| 422 | LXRX | Lexicon Pharmaceuticals, Inc. | 658.53M | 2.07% | 1,861,629 | 41.47M |
| 423 | AURA | Aura Biosciences, Inc. | 653.34M | 1.94% | 680,181 | - |
| 424 | SOPH | SOPHiA GENETICS SA | 641.86M | 0.27% | 303,791 | 86.17M |
| 425 | CADL | Candel Therapeutics, Inc. | 631.28M | 5.91% | 928,433 | - |
| 426 | CRMD | CorMedix Inc. | 623.55M | 0.76% | 1,002,268 | 462.25M |
| 427 | KIDS | OrthoPediatrics Corp. | 621.94M | -0.83% | 378,235 | 252.72M |
| 428 | OLMA | Olema Pharmaceuticals, Inc. | 615.98M | 6.34% | 2,190,088 | - |
| 429 | DBVT | DBV Technologies S.A. | 609.96M | 1.45% | 641,348 | 5.04M |
| 430 | MYGN | Myriad Genetics, Inc. | 601.64M | 4.49% | 2,244,311 | 806.60M |
| 431 | NVCT | Nuvectis Pharma, Inc. | 600.80M | -0.27% | 144,605 | - |
| 432 | ZVRA | Zevra Therapeutics, Inc. | 597.10M | 5.51% | 1,088,794 | 136.07M |
| 433 | EVO | Evotec SE | 588.33M | 3.29% | 42,405 | 819.47M |
| 434 | AVR | Anteris Technologies Global Corp. | 584.96M | 3.81% | 1,480,448 | 2.24M |
| 435 | IRWD | Ironwood Pharmaceuticals, Inc. | 579.99M | 0.29% | 1,655,126 | 389.32M |
| 436 | STTK | Shattuck Labs, Inc. | 579.10M | 4.15% | 699,950 | 1.00M |
| 437 | FLGT | Fulgent Genetics, Inc. | 569.57M | 2.37% | 355,832 | 323.93M |
| 438 | MDXG | MiMedx Group, Inc. | 568.47M | 1.30% | 1,920,333 | 355.17M |
| 439 | CBIO | Crescent Biopharma, Inc. | 567.97M | 4.00% | 288,223 | 11.88M |
| 440 | PBYI | Puma Biotechnology, Inc. | 563.69M | 0.65% | 242,944 | 231.24M |
| 441 | ACRS | Aclaris Therapeutics, Inc. | 557.88M | - | 7,986,029 | 8.22M |
| 442 | CLYM | Climb Bio, Inc. | 549.66M | 8.63% | 3,904,197 | - |
| 443 | NGNE | Neurogene Inc. | 540.11M | 14.66% | 484,687 | 925.00K |
| 444 | ETRA | Electra Therapeutics, Inc. | 534.77M | 1.79% | 176,832 | - |
| 445 | ENTX | Entera Bio Ltd. | 532.20M | 6.99% | 203,504 | 42.00K |
| 446 | TCMD | Tactile Systems Technology, Inc. | 531.42M | 0.30% | 188,653 | 350.31M |
| 447 | DRUG | Bright Minds Biosciences Inc. | 530.84M | 5.73% | 59,397 | - |
| 448 | VALN | Valneva SE | 523.40M | 2.96% | 16,130 | 163.30M |
| 449 | SRZN | Surrozen, Inc. | 516.63M | 8.25% | 431,554 | 11.51M |
| 450 | ANGO | AngioDynamics, Inc. | 515.59M | 0.74% | 570,598 | 325.38M |
| 451 | DCTH | Delcath Systems, Inc. | 511.81M | 1.65% | 245,056 | 95.42M |
| 452 | MASS | 908 Devices Inc. | 510.88M | 6.09% | 426,851 | 60.84M |
| 453 | AQST | Aquestive Therapeutics, Inc. | 510.83M | 2.52% | 1,324,899 | 54.09M |
| 454 | INDP | Indaptus Therapeutics, Inc. | 507.59M | -1.05% | 366,383 | - |
| 455 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 456 | CTMX | CytomX Therapeutics, Inc. | 503.35M | 3.82% | 3,734,078 | 18.30M |
| 457 | SSII | SS Innovations International, Inc. | 500.96M | 5.49% | 105,812 | 52.40M |
| 458 | BLSM | BlossomHill Therapeutics, Inc. | 500.77M | -3.87% | 74,306 | - |
| 459 | EVH | Evolent Health, Inc. | 499.72M | -2.43% | 1,294,342 | 2.10B |
| 460 | SGHT | Sight Sciences, Inc. | 497.44M | 0.11% | 266,128 | 83.38M |
| 461 | RCEL | AVITA Medical, Inc. | 497.30M | 5.93% | 545,247 | 75.63M |
| 462 | FTH | Faeth Therapeutics, Inc. | 493.81M | 13.55% | 612,172 | - |
| 463 | ARVN | Arvinas, Inc. | 487.13M | 1.92% | 800,824 | 316.70M |
| 464 | EOLS | Evolus, Inc. | 486.79M | 2.79% | 600,999 | 316.49M |
| 465 | CERS | Cerus Corporation | 483.66M | 1.27% | 3,828,331 | 221.55M |
| 466 | OCS | Oculis Holding AG | 483.36M | -1.63% | 189,294 | 1.45M |
| 467 | MNPR | Monopar Therapeutics Inc. | 482.20M | 1.84% | 135,923 | - |
| 468 | NRC | NRC Health | 481.10M | -3.12% | 105,713 | 143.79M |
| 469 | PHAT | Phathom Pharmaceuticals, Inc. | 475.79M | 0.84% | 2,103,877 | 239.66M |
| 470 | DMAC | DiaMedica Therapeutics Inc. | 468.61M | -0.57% | 268,714 | - |
| 471 | EPRX | Eupraxia Pharmaceuticals Inc. | 464.03M | 3.36% | 486,204 | - |
| 472 | PROK | ProKidney Corp. | 458.02M | 11.40% | 1,367,503 | 818.00K |
| 473 | MPLT | MapLight Therapeutics, Inc. | 454.05M | 6.66% | 384,829 | - |
| 474 | PRTA | Prothena Corporation plc | 452.28M | 4.88% | 654,349 | 54.53M |
| 475 | BWAY | BrainsWay Ltd. | 451.36M | 3.75% | 74,164 | 60.70M |
| 476 | KMDA | Kamada Ltd. | 450.43M | 1.39% | 73,825 | 191.85M |
| 477 | NPCE | NeuroPace, Inc. | 446.90M | 0.23% | 67,235 | 106.99M |
| 478 | OVID | Ovid Therapeutics Inc. | 441.37M | 4.87% | 1,691,775 | 1.58M |
| 479 | SENS | Senseonics Holdings, Inc. | 440.44M | 11.36% | 824,609 | 48.55M |
| 480 | TKNO | Alpha Teknova, Inc. | 438.71M | 7.89% | 453,910 | 43.70M |
| 481 | RGNX | REGENXBIO Inc. | 435.69M | 0.30% | 1,222,877 | 174.48M |
| 482 | RZLT | Rezolute, Inc. | 431.13M | 7.59% | 1,400,113 | - |
| 483 | YDES | YD Bio Limited | 427.82M | 14.18% | 47,027 | 1.24M |
| 484 | ALLO | Allogene Therapeutics, Inc. | 424.95M | 1.65% | 16,102,778 | 4.64M |
| 485 | CARL | Carlsmed, Inc. | 421.01M | 3.42% | 99,621 | 63.30M |
| 486 | SRTA | Strata Critical Medical, Inc. | 417.56M | -0.84% | 911,443 | 255.98M |
| 487 | AGMB | AgomAb Therapeutics NV | 413.68M | -1.98% | 89,797 | - |
| 488 | ASMB | Assembly Biosciences, Inc. | 413.32M | 3.20% | 185,733 | 74.85M |
| 489 | AUTL | Autolus Therapeutics plc | 412.55M | 1.31% | 1,744,482 | 117.39M |
| 490 | ZURA | Zura Bio Limited | 409.19M | 19.94% | 5,083,977 | - |
| 491 | TLRY | Tilray Brands, Inc. | 406.26M | 1.84% | 2,516,332 | 963.10M |
| 492 | SI | Shoulder Innovations, Inc. | 402.64M | -0.21% | 135,916 | 60.06M |
| 493 | PRLD | Prelude Therapeutics Incorporated | 399.62M | 4.86% | 276,651 | 22.42M |
| 494 | EDIT | Editas Medicine, Inc. | 399.31M | 8.33% | 3,078,302 | 47.01M |
| 495 | TECX | Tectonic Therapeutic, Inc. | 397.63M | 1.95% | 226,968 | - |
| 496 | ALT | Altimmune, Inc. | 396.82M | -0.49% | 4,463,432 | 31.00K |
| 497 | OFIX | Orthofix Medical Inc. | 395.51M | -0.72% | 301,180 | 833.19M |
| 498 | CCCC | C4 Therapeutics, Inc. | 394.91M | 7.72% | 4,118,932 | 35.04M |
| 499 | CYH | Community Health Systems, Inc. | 384.90M | -3.40% | 1,772,786 | 11.98B |
| 500 | CTEV | Claritev Corporation | 383.86M | 5.15% | 322,712 | 994.67M |